KEGG   DRUG: Etuvetidigene autotemcel
Entry
D13348                      Drug                                   
Name
Etuvetidigene autotemcel (USAN/INN);
Waskyra (TN)
Product
WASKYRA (Fondazione Telethon ETS), WASKYRA (Orphan Therapies LLC)
Remark
Product: D13348<US>
Efficacy
Hereditary disorder therapeutic agent
  Disease
Wiskott-Aldrich syndrome [DS:H01523]
  Type
Cellular therapy product
Comment
Treatment of Wiskott-Aldrich syndrome
Target
WAS [HSA:7454] [KO:K05747]
Brite
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D13348
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D13348
Other DBs
PubChem: 528799051
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system